Invention Grant
- Patent Title: Bromodomain inhibitors
-
Application No.: US15216855Application Date: 2016-07-22
-
Publication No.: US10085985B2Publication Date: 2018-10-02
- Inventor: Andrew Bogdan , Warren M. Kati , Keith F. McDaniel , Chang H. Park , George S. Sheppard , Le Wang
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Michael S. Montgomery
- Priority: WOPCT/CN2013/088844 20131209
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D487/04 ; C07D211/86 ; C07D405/04 ; C07D401/04 ; C07D417/04 ; C07D401/12 ; C07D405/12 ; C07D413/12 ; C07D417/12 ; C07D213/69 ; A61K31/4412 ; A61K31/4433 ; A61K31/4439 ; A61K31/444 ; A61K31/4709 ; A61K31/497
Abstract:
The present invention provides for compounds of formula (I) wherein Y1, Y2, R1, R2, R3, A1, A2, A3, and A4, have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
Public/Granted literature
- US20160331749A1 BROMODOMAIN INHIBITORS Public/Granted day:2016-11-17
Information query
IPC分类:
